Literature DB >> 7539279

Two tumor suppressive loci on chromosome 10 involved in human glioblastomas.

P A Steck1, A H Ligon, P Cheong, W K Yung, M A Pershouse.   

Abstract

A number of cytogenetic and molecular analyses have revealed very frequent and extensive losses of regions of chromosome 10 in human glioblastomas. Our recent studies have demonstrated that the transfer of a chromosome 10 into human glioblastoma cells resulted in suppression of their transformed and tumorigenic phenotype. To localize the suppressive region further, we isolated and characterized certain hybrid cells that had undergone chromosomal rearrangements to yield hybrid cells retaining only various regions of the inserted chromosome 10. One series of subclones showed the loss of the majority of the long arm of chromosome 10 (10q21-10qter) and regained the ability to grow under anchorage-independent conditions, but the cells still failed to exhibit significant tumorigenicity in nude mice. Another set of subclones exhibited major deletions of large segments of the long arm of chromosome 10 (10q21-q23; 10q26-qter), yet retained certain distal alleles associated with 10q24 to 10q26. These subclones were identical in their biological characteristics to the hybrids containing an intact chromosome 10, exhibiting no growth in soft agarose or in nude mice. These results implicate the presence of two independent phenotypically suppressive regions on chromosome 10 (10pter-q11 and 10q24-q26) that are involved in glioma progression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539279     DOI: 10.1002/gcc.2870120404

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  21 in total

1.  MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma.

Authors:  Mark Katakowski; Xuguang Zheng; Feng Jiang; Thomas Rogers; Alexandra Szalad; Michael Chopp
Journal:  Cancer Invest       Date:  2010-09-27       Impact factor: 2.176

Review 2.  Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

Authors:  Jean-Philip Truman; Mónica García-Barros; Lina M Obeid; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-12-30

3.  PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells.

Authors:  D M Li; H Sun
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

4.  PTEN: sometimes taking it off can be better than putting it on.

Authors:  M P Myers; N K Tonks
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

5.  PAX6 suppresses growth of human glioblastoma cells.

Authors:  Yi-Hong Zhou; Xiaosong Wu; Fang Tan; Yue-Xi Shi; Tricia Glass; T J Liu; Kyle Wathen; Kenneth R Hess; Joy Gumin; Frederick Lang; W K Alfred Yung
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

6.  Identification of PTEN mutations in metastatic melanoma specimens.

Authors:  J T Celebi; I Shendrik; D N Silvers; M Peacocke
Journal:  J Med Genet       Date:  2000-09       Impact factor: 6.318

Review 7.  Crosstalk between sphingolipids and vitamin D3: potential role in the nervous system.

Authors:  Mercedes Garcia-Gil; Federica Pierucci; Ambra Vestri; Elisabetta Meacci
Journal:  Br J Pharmacol       Date:  2017-02-24       Impact factor: 8.739

8.  In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma.

Authors:  G P Robertson; F B Furnari; M E Miele; M J Glendening; D R Welch; J W Fountain; T G Lugo; H J Huang; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

9.  Identification of an alternatively spliced RNA for the Ras suppressor RSU-1 in human gliomas.

Authors:  Suryaprabha Chunduru; Hiroyuki Kawami; Richard Gullick; William J Monacci; Gerard Dougherty; Mary Lou Cutler
Journal:  J Neurooncol       Date:  2002-12       Impact factor: 4.130

10.  Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations.

Authors:  ChongFeng Gao; Kyle Furge; Julie Koeman; Karl Dykema; Yanli Su; Mary Lou Cutler; Adam Werts; Pete Haak; George F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.